Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Nutrients ; 14(20)2022 Oct 19.
Artículo en Inglés | MEDLINE | ID: mdl-36297062

RESUMEN

Infants are frequently supplemented with iron to prevent iron deficiency, but iron supplements may have adverse effects on infant health. Although iron supplements can be highly effective at improving iron status and preventing iron deficiency anemia, iron may adversely affect growth and development, and may increase risk for certain infections. Several reviews exist in this area; however, none has fully summarized all reported outcomes of iron supplementation during infancy. In this review, we summarize the risks and benefits of iron supplementation as they have been reported in controlled studies and in relevant animal models. Additionally, we discuss the mechanisms that may underly beneficial and adverse effects.


Asunto(s)
Anemia Ferropénica , Deficiencias de Hierro , Animales , Hierro/efectos adversos , Anemia Ferropénica/prevención & control , Suplementos Dietéticos/efectos adversos , Medición de Riesgo
2.
Nutrients ; 14(19)2022 Sep 21.
Artículo en Inglés | MEDLINE | ID: mdl-36235565

RESUMEN

Iron supplements are frequently provided to infants in high-income countries despite low incidence of iron deficiency. There is growing concern regarding adverse health and development outcomes of excess iron provision in early life. Excess iron may directly damage developing organs through the formation of reactive oxygen species, alter systemic inflammatory signaling, and/or dysregulate trace mineral metabolism. To better characterize the in vivo effects of excess iron on development, we utilized a pre-weanling rat pup model. Lewis rat litters were culled to eight pups (four males and four females) and randomly assigned to daily supplementation groups receiving either vehicle control (CON; 10% w/v sucrose solution) or ferrous sulfate (FS) iron at one of the following doses: 10, 30, or 90 mg iron/kg body weight-FS-10, FS-30, and FS-90, respectively-from postnatal day (PD) 2 through 9. FS-90 litters, but not FS-30 or FS-10, failed to thrive compared to CON litters and had smaller brains on PD 10. Among the groups, FS-90 liver iron levels were highest, as were white blood cell counts. Compared to CON, circulating MCP-1 and liver zinc were increased in FS-90 pups, whereas liver copper was decreased. Growth defects due to excess FS provision in pre-weanling rats may be related to liver injury, inflammation, and altered trace mineral metabolism.


Asunto(s)
Sobrecarga de Hierro , Oligoelementos , Animales , Cobre , Suplementos Dietéticos , Femenino , Compuestos Ferrosos , Hierro/metabolismo , Masculino , Ratas , Ratas Endogámicas Lew , Especies Reactivas de Oxígeno , Sacarosa , Oligoelementos/farmacología , Zinc
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA